Anja Schütz

5PUBLICATIONS
36CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsRespiratory diseasesMedical biotechnology diagnostics (incl. biosensors)Pharmaceutical delivery technologiesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 19, 2025
Selectivity and Safety Characterization of a Xanthine-Imidazothiazole Lead Structure: a Novel Tryptophan Hydroxylase Inhibitor of Peripheral Serotonin Synthesis.

Radoslaw Wesolowski, Anja Schütz, Michael Lisurek

|May 30, 2025
IL-36 signaling as a drug target in Crohn's disease patients with IL36RN mutations.

Julia Hecker, Christina Plattner, Camila A Cancino

|Sep 13, 2024
CRISPR-enabled point-of-care genotyping for APOL1 genetic risk assessment.

Robert Greensmith, Isadora T Lape, Cristian V Riella

|Mar 12, 2024
AI-guided pipeline for protein-protein interaction drug discovery identifies a SARS-CoV-2 inhibitor.

Philipp Trepte, Christopher Secker, Julien Olivet

|Oct 16, 2023
An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor.

Tim Aguirre, Gillian L Dornan, Sarah Hostachy

Pageof 1

Frequent Collaborators

2 joint publications

Michael Lisurek

1 joint publications

Tim Aguirre

1 joint publications

Sarah Hostachy

1 joint publications

Martin Neuenschwander